NR568/ NR 568 ADVANCED PHARMACOLOGY WEEKS 5-8 FINAL EXAM] QUESTIONS AND CORRECT
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains:
• Hormone Replacement Therapy (HRT) in Men and Women
• Contraceptive Pharmacology and Mechanisms of Action
• Androgen Therapy and Testosterone Replacement
• Pharmacotherapy for Erectile Dysfunction (ED)
• Management of Benign Prostatic Hyperplasia (BPH)
• Pharmacological Treatment of Sexually Transmitted Infections (STIs)
• Pharmacokinetics and Pharmacodynamics of Endocrine Agents
• Drug-Drug Interactions and Adverse Effect Profiles
• Clinical Decision-Making and Patient Counseling
Introduction
This comprehensive examination is designed to assess your advanced knowledge and clinical application skills in
the pharmacological management of endocrine and genitourinary conditions, specifically focusing on hormone
therapy, contraceptives, androgens, erectile dysfunction, benign prostatic hyperplasia, and sexually transmitted
infections. The exam is structured to evaluate both foundational theory and complex, real-world clinical decision-
making. You will encounter a variety of multiple-choice questions and scenario-based problems that challenge you
to integrate pharmacotherapeutic principles with patient-specific factors, ethical considerations, and regulatory
guidelines. This assessment emphasizes safe prescribing practices, monitoring parameters, and the ability to tailor
treatment plans to optimize patient outcomes while minimizing risks.
,Section One: Questions 1-100
1. A 55-year-old male with a history of ischemic heart disease is asking about testosterone replacement
therapy (TRT) for symptomatic hypogonadism. Which of the following is the most significant
contraindication to initiating TRT in this patient?
A. Elevated serum estradiol levels
B. A hematocrit of 48%
C. A history of untreated severe obstructive sleep apnea
D. A PSA of 2.8 ng/mL
🟢 C. A history of untreated severe obstructive sleep apnea
🔴 RATIONALE: Testosterone can exacerbate sleep apnea due to its effects on respiratory drive and upper
airway stability during sleep. While elevated estradiol, hematocrit, and PSA require monitoring and may be
relative contraindications, untreated severe obstructive sleep apnea is a significant absolute contraindication
due to the risk of worsening the condition and its cardiovascular consequences. Current guidelines strongly
caution against TRT in men with untreated, severe sleep apnea.
2. A 28-year-old female who smokes heavily and has a history of migraine with aura is requesting oral
contraceptive pills (OCPs). Which type of contraceptive is most strongly contraindicated for this patient?
A. Progestin-only pill
B. Combined hormonal contraceptive (CHC) containing ethinyl estradiol and drospirenone
C. Copper intrauterine device (IUD)
D. Depot medroxyprogesterone acetate (DMPA) injection
🟢 B. Combined hormonal contraceptive (CHC) containing ethinyl estradiol and drospirenone
,🔴 RATIONALE: Combined hormonal contraceptives are contraindicated in women who smoke heavily (>15
cigarettes/day) and are over 35, and in women with a history of migraine with aura due to a significantly
increased risk of thrombotic events and stroke. The estrogen component is the primary driver of this increased
risk. The progestin-only pill, copper IUD, and DMPA do not contain estrogen and do not carry the same level of
thrombotic risk, making them safer alternatives for this patient.
3. A 72-year-old male with moderate lower urinary tract symptoms (LUTS) secondary to BPH is started on
tamsulosin. Which of the following adverse effects is most specific to this medication class and requires
specific patient counseling?
A. Orthostatic hypotension and dizziness
B. Retrograde ejaculation
C. Headache and rhinitis
D. Prolonged QT interval
🟢 B. Retrograde ejaculation
🔴 RATIONALE: Retrograde ejaculation is a side effect highly specific to alpha-1 blockers, particularly
tamsulosin, due to its selective action on alpha-1A receptors in the prostate and bladder neck, leading to
relaxation of the bladder neck and loss of seminal emission. While orthostatic hypotension, headache, and
rhinitis are also possible adverse effects of alpha-1 blockers, retrograde ejaculation is a unique and relatively
common side effect (reported in up to 18% of patients) that requires specific counseling to prevent patient
distress and misunderstanding.
4. A 30-year-old male presents with dysuria and a purulent urethral discharge. A Gram stain reveals
intracellular gram-negative diplococci. Which of the following is the recommended first-line treatment for
uncomplicated gonococcal urethritis, according to current CDC guidelines?
, A. Azithromycin 1g orally as a single dose
B. Ceftriaxone 500 mg intramuscularly as a single dose
C. Doxycycline 100 mg orally twice daily for 7 days
D. Ciprofloxacin 500 mg orally as a single dose
🟢 B. Ceftriaxone 500 mg intramuscularly as a single dose
🔴 RATIONALE: Due to increasing resistance, the CDC currently recommends ceftriaxone 500 mg IM as a single
dose for uncomplicated urogenital, rectal, and pharyngeal gonorrhea. Azithromycin is no longer recommended
as part of routine dual therapy. Doxycycline is used for chlamydia co-infection, and ciprofloxacin is not
recommended due to high rates of fluoroquinolone resistance. This regimen reflects updated guidelines to
ensure effective treatment and combat antimicrobial resistance.
5. A 65-year-old male is being evaluated for erectile dysfunction. He has a history of hypertension and is
currently well-controlled on amlodipine. He also takes dutasteride for BPH. Which of the following
phosphodiesterase type 5 (PDE5) inhibitors has a known drug interaction with dutasteride?
A. Sildenafil
B. Tadalafil
C. Vardenafil
D. Avanafil
🟢 B. Tadalafil
🔴 RATIONALE: Tadalafil is FDA-approved for the treatment of both erectile dysfunction and BPH. It is known to
have a mild pharmacokinetic interaction with dutasteride, as both are metabolized by CYP3A4. While this
interaction does not require a dose adjustment, it is important to recognize because tadalafil is the only PDE5
ANSWERS (VERIFIED ANSWERS) PLUS RATIONALES 2026 Q&A | INSTANT DOWNLOAD PDF.
Core Domains:
• Hormone Replacement Therapy (HRT) in Men and Women
• Contraceptive Pharmacology and Mechanisms of Action
• Androgen Therapy and Testosterone Replacement
• Pharmacotherapy for Erectile Dysfunction (ED)
• Management of Benign Prostatic Hyperplasia (BPH)
• Pharmacological Treatment of Sexually Transmitted Infections (STIs)
• Pharmacokinetics and Pharmacodynamics of Endocrine Agents
• Drug-Drug Interactions and Adverse Effect Profiles
• Clinical Decision-Making and Patient Counseling
Introduction
This comprehensive examination is designed to assess your advanced knowledge and clinical application skills in
the pharmacological management of endocrine and genitourinary conditions, specifically focusing on hormone
therapy, contraceptives, androgens, erectile dysfunction, benign prostatic hyperplasia, and sexually transmitted
infections. The exam is structured to evaluate both foundational theory and complex, real-world clinical decision-
making. You will encounter a variety of multiple-choice questions and scenario-based problems that challenge you
to integrate pharmacotherapeutic principles with patient-specific factors, ethical considerations, and regulatory
guidelines. This assessment emphasizes safe prescribing practices, monitoring parameters, and the ability to tailor
treatment plans to optimize patient outcomes while minimizing risks.
,Section One: Questions 1-100
1. A 55-year-old male with a history of ischemic heart disease is asking about testosterone replacement
therapy (TRT) for symptomatic hypogonadism. Which of the following is the most significant
contraindication to initiating TRT in this patient?
A. Elevated serum estradiol levels
B. A hematocrit of 48%
C. A history of untreated severe obstructive sleep apnea
D. A PSA of 2.8 ng/mL
🟢 C. A history of untreated severe obstructive sleep apnea
🔴 RATIONALE: Testosterone can exacerbate sleep apnea due to its effects on respiratory drive and upper
airway stability during sleep. While elevated estradiol, hematocrit, and PSA require monitoring and may be
relative contraindications, untreated severe obstructive sleep apnea is a significant absolute contraindication
due to the risk of worsening the condition and its cardiovascular consequences. Current guidelines strongly
caution against TRT in men with untreated, severe sleep apnea.
2. A 28-year-old female who smokes heavily and has a history of migraine with aura is requesting oral
contraceptive pills (OCPs). Which type of contraceptive is most strongly contraindicated for this patient?
A. Progestin-only pill
B. Combined hormonal contraceptive (CHC) containing ethinyl estradiol and drospirenone
C. Copper intrauterine device (IUD)
D. Depot medroxyprogesterone acetate (DMPA) injection
🟢 B. Combined hormonal contraceptive (CHC) containing ethinyl estradiol and drospirenone
,🔴 RATIONALE: Combined hormonal contraceptives are contraindicated in women who smoke heavily (>15
cigarettes/day) and are over 35, and in women with a history of migraine with aura due to a significantly
increased risk of thrombotic events and stroke. The estrogen component is the primary driver of this increased
risk. The progestin-only pill, copper IUD, and DMPA do not contain estrogen and do not carry the same level of
thrombotic risk, making them safer alternatives for this patient.
3. A 72-year-old male with moderate lower urinary tract symptoms (LUTS) secondary to BPH is started on
tamsulosin. Which of the following adverse effects is most specific to this medication class and requires
specific patient counseling?
A. Orthostatic hypotension and dizziness
B. Retrograde ejaculation
C. Headache and rhinitis
D. Prolonged QT interval
🟢 B. Retrograde ejaculation
🔴 RATIONALE: Retrograde ejaculation is a side effect highly specific to alpha-1 blockers, particularly
tamsulosin, due to its selective action on alpha-1A receptors in the prostate and bladder neck, leading to
relaxation of the bladder neck and loss of seminal emission. While orthostatic hypotension, headache, and
rhinitis are also possible adverse effects of alpha-1 blockers, retrograde ejaculation is a unique and relatively
common side effect (reported in up to 18% of patients) that requires specific counseling to prevent patient
distress and misunderstanding.
4. A 30-year-old male presents with dysuria and a purulent urethral discharge. A Gram stain reveals
intracellular gram-negative diplococci. Which of the following is the recommended first-line treatment for
uncomplicated gonococcal urethritis, according to current CDC guidelines?
, A. Azithromycin 1g orally as a single dose
B. Ceftriaxone 500 mg intramuscularly as a single dose
C. Doxycycline 100 mg orally twice daily for 7 days
D. Ciprofloxacin 500 mg orally as a single dose
🟢 B. Ceftriaxone 500 mg intramuscularly as a single dose
🔴 RATIONALE: Due to increasing resistance, the CDC currently recommends ceftriaxone 500 mg IM as a single
dose for uncomplicated urogenital, rectal, and pharyngeal gonorrhea. Azithromycin is no longer recommended
as part of routine dual therapy. Doxycycline is used for chlamydia co-infection, and ciprofloxacin is not
recommended due to high rates of fluoroquinolone resistance. This regimen reflects updated guidelines to
ensure effective treatment and combat antimicrobial resistance.
5. A 65-year-old male is being evaluated for erectile dysfunction. He has a history of hypertension and is
currently well-controlled on amlodipine. He also takes dutasteride for BPH. Which of the following
phosphodiesterase type 5 (PDE5) inhibitors has a known drug interaction with dutasteride?
A. Sildenafil
B. Tadalafil
C. Vardenafil
D. Avanafil
🟢 B. Tadalafil
🔴 RATIONALE: Tadalafil is FDA-approved for the treatment of both erectile dysfunction and BPH. It is known to
have a mild pharmacokinetic interaction with dutasteride, as both are metabolized by CYP3A4. While this
interaction does not require a dose adjustment, it is important to recognize because tadalafil is the only PDE5
